Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03969056 · ClinicalTrials.gov registry record · NA
AI Activity Study in Patients With Elevated Blood Pressure
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03969056: Clinical Trial NA study, sponsored by University of California, San Francisco.
NCT03969056 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03969056, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
In this pilot RCT, a total of 40 adults with hypertension will be randomized to either an artificial intelligence (AI) physical activity intervention group or an active control group with a 1 to 1 ratio after completing a 2-week run-in period and 4-week training. The AI intervention group will receive an automated and personalized daily step goal intervention involving a sophisticated activity analytics algorithm using advanced statistics and machine learning, while the active control group will receive a standardized and fixed 10,000 daily steps goal. Both groups will receive an identical smartphone app (app content differs between the two groups) and ActiGraph GT9X Link to assess objectively measured physical activity (primary outcome) during the study period.
Primary Outcome
measured by ActiGraph GT9X Link\]
Interventions
- BEHAVIORAL 10,000 steps
- BEHAVIORAL Artificial Intelligence (AI) Activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2020-02-06 |
| Est. Completion | 2020-04-30 |
| Phase | NA |
Why NCT03969056 stopped before completion
NCT03969056 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which 10,000 steps is the first listed.
NCT03969056 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03969056 about?
NCT03969056 is a clinical study titled "AI Activity Study in Patients With Elevated Blood Pressure". In this pilot RCT, a total of 40 adults with hypertension will be randomized to either an artificial intelligence (AI) physical activity intervention group or an active control group with a 1 to 1 ratio after completing a 2-week run-in period and 4-week training. The AI intervention group will recei...
What is the current status of trial NCT03969056?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2020-02-06. Estimated completion is 2020-04-30.
What interventions are being tested in trial NCT03969056?
The interventions under investigation include: 10,000 steps (BEHAVIORAL), Artificial Intelligence (AI) Activity (BEHAVIORAL).
Who is sponsoring clinical trial NCT03969056?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03969056's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI